Share -->PrintHomeGlobal Health PolicyKaiser Daily Global Health Policy ReportMay 19, 2015Boosting Antibiotic Research, Development Pipeline Critical To Ending Drug ResistanceMay 19, 2015

The Guardian: Antibiotic resistance is a growing menace — we must act before it’s too late
John McConnell, editor of The Lancet Infectious Diseases

“…Profligate use of antibiotics has provided the evolutionary driver for bacteria to develop resistance to the drugs. Introduction of every new class of antibiotics has been followed by bacteria becoming resistant. … Ways to boost the research and development pipeline for new antibiotics are the focus of the latest report, released last week, from the Review on Antimicrobial Resistance (AMR), chaired by economist Jim O’Neill. … The latest paper suggests ways to revitalize the research and development pipeline to produce about 15 new licensed antibiotics every 10 years. … AMR will contribute to 10 million annual deaths worldwide by 2050, more even than cancer. By boosting the antibiotic pipeline — one of several measures needed to combat this crisis — we can start to take our fate into our own hands…” (5/18).

Share -->PrintHomeGlobal Health PolicyKaiser Daily Global Health Policy ReportMay 19, 2015U.S. Must Maintain Investments In HIV Vaccine, Prevention ResearchMay 19, 2015

The Hill: Choosing the worst time to scale back AIDS research
Mitchell Warren, executive director of AVAC

“…For the first time, we can honestly talk about how to end the AIDS epidemic — and we have not only researchers, advocates, and trial participants to thank, but also American taxpayers. But we don’t yet have all the tools we need. That’s why it is dismaying that some members of Congress have chosen this moment to call for scaling back the nation’s investments in HIV research. Instead, we should be looking for ways to make these investments even more impactful, to continue leading the world into a future without AIDS…” (5/18).